ReviewInternational journal of pharmaceutics: X2026
Ligand-modified liposomes as drug delivery systems for the active targeting of pancreatic cancer.
Yerin Jang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it